NEWSROOM
Here you will find the ad hoc announcements and corporate news of Darwin AG for viewing and downloading as a PDF file.
-
Darwin AG launches commercialization of Multi-Cancer Check — a blood test for early detection of 13 types of cancer 18.03.2026Read more
-
Darwin AG Announces Preliminary Group Revenue for 2025 and Confirms Strategic Growth Trajectory 25.02.2026Read more
-
Corporate News Preliminary Group Revenue 2025 2026Download
-
Corporate News Cancer test 2026Download
-
Corporate News Forecast 2026-2029 2026Download
-
Corporate News Q3 results 2025Download
-
Corporate News Sales Partnership Hartlauer 2025Download
-
Corporate News Partnership UAE 2025Download
-
Corporate News Medical Genetics 2025Download
-
Corporate News Issuer Report 2025Download
-
Implementation Stock Split 2025Download
-
Stock Split in Ratio 1:3 Resolved 2025Download
-
Turnover 2024 Outlook 2025 2025Download
-
AD-HOC Announcement Acquisition MEDICOPHARM 2024Download
-
Acquisition MEDICOPHARM 2024Download
-
Darwin AG publishes issuer report for the first half of 2024 2024Download
-
Darwin AG: Subsidiary 305 Care starts with successful market launch 2024Download
-
AD-HOC-NOTIFICATION: Darwin Group signs supply agreement for genetic tests and nutritional supplements with Cardone Ventures LLC 2024Download
-
CORPORATE NEWS: Darwin AG participates in funding round at GenePlanet – access to growth markets in Eastern Europe 2023Download
-
AD-HOC-NOTIFICATION: Darwin AG acquires majority of the shares in INOPHA GmbH and ChiruTec GmbH. (german) 2023Download
-
AD-HOC-NOTIFICATION: Novogenia Holding AG is aware of sales estimates for 2021 due to the ongoing testing requirements in the context of the corona pandemic (german) 2021Download
-
CORPORATE NEWS: Core competencies and business areas 2021Download
-
AD-HOC-NOTIFICATION: Board member Markus Wenner is stepping down from his mandate as planned 2021Download
GENOPEDIA
Browse through our online encyclopedia for genetics and see what our Deep Genome AI engine has gathered from millions of scientific publications as a basis of automated genome analysis.
